Back
Enanta Pharmaceuticals Vs. Cassava Sciences Industry Stock Comparison
Sell
29
ENTA
Enanta Pharmaceuticals
Last Price:
$6.78
Seasonality Move:
-8.07%
Sell
35
SAVA
Cassava Sciences
Last Price:
$2.66
Seasonality Move:
11.4%
Sell
29
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy, Sell or Hold?
-
The current Enanta Pharmaceuticals [ENTA] share price is $7.22. The Score for ENTA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ENTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
-
The current Cassava Sciences [SAVA] share price is $2.81. The Score for SAVA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
SAVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENTA Stock Price Chart
What is Enanta Pharmaceuticals's stock price today?
-
The Enanta Pharmaceuticals share price today is $7.22Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing buying pressure, which is a positive indicator for future bullish movement.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $2.81The current trend is relatively stagnant and SAVA is experiencing slight selling pressure.
ENTA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 53.87 | Buy |
Chaikin Money Flow: | 97167 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.39 - 7.97) | Buy |
Bollinger Bands (100): | (5.47 - 10.43) | Sell |
SAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 53.22 | Buy |
Chaikin Money Flow: | -230202 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.32 - 2.66) | Buy |
Bollinger Bands (100): | (-0.89 - 21.79) | Sell |
ENTA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.47 | Sell |
20-day SMA: | 7.07 | Buy |
50-day SMA: | 6.07 | Buy |
200-day SMA: | 10.36 | Sell |
8-day EMA: | 7.36 | Sell |
20-day EMA: | 7.07 | Buy |
50-day EMA: | 6.88 | Buy |
200-day EMA: | 9.82 | Sell |
SAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.61 | Buy |
20-day SMA: | 2.51 | Buy |
50-day SMA: | 2.55 | Buy |
200-day SMA: | 16.45 | Sell |
8-day EMA: | 2.67 | Buy |
20-day EMA: | 2.6 | Buy |
50-day EMA: | 4.18 | Sell |
200-day EMA: | 13.59 | Sell |
Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.26 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and a decrease next year of $1.54 per share.
Enanta Pharmaceuticals Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cassava Sciences Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |